ArticleCancer chemotherapy and pharmacology2023

The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.

Martina Jabloñski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.